Joel Greenblatt's HRMY Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 64,184 shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $1.8 M, representing 0.01% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in HRMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 44,969 shares. Largest reduction occurred in Q1 2025, reducing 27,339 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +32,411 | Add 102.01% | 64,184 | $28.01 |
| Q4 2025 | -7,125 | Reduce 18.32% | 31,773 | $37.42 |
| Q3 2025 | -809 | Reduce 2.04% | 38,898 | $27.56 |
| Q2 2025 | +16,544 | Add 71.42% | 39,707 | $31.60 |
| Q1 2025 | -27,339 | Reduce 54.13% | 23,163 | $33.19 |
| Q4 2024 | -16,220 | Reduce 24.31% | 50,502 | $34.41 |
| Q3 2024 | -18,283 | Reduce 21.51% | 66,722 | $40.00 |
| Q2 2024 | +1,277 | Add 1.53% | 85,005 | $30.17 |
| Q1 2024 | +1,530 | Add 1.86% | 83,728 | $33.58 |
| Q4 2023 | +18,334 | Add 28.71% | 82,198 | $32.30 |
| Q3 2023 | -8,838 | Reduce 12.16% | 63,864 | $32.77 |
| Q2 2023 | +44,969 | Add 162.15% | 72,702 | $35.19 |
| Q1 2023 | +27,733 | New Buy | 27,733 | $32.65 |
| Q4 2022 | -19,684 | Sold Out | 0 | $0.00 |
| Q3 2022 | +19,684 | New Buy | 19,684 | $44.30 |
Joel Greenblatt's Harmony Biosciences Holdings Investment FAQs
Joel Greenblatt first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q3 2022, acquiring 19,684 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Harmony Biosciences Holdings, Inc. (HRMY) for 15 quarters since Q3 2022.
Joel Greenblatt's largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q2 2023, adding 72,702 shares worth $2.56 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 64,184 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $1.8 M.
As of the Q1 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 85,005 shares, as reported at the end of Q2 2024.